Drug
Cholesterol-binding protein clinical trials
Also written PRT-201 and vonapanitase.
- studies test it
- 8
- open now
- 0
- in phase 3
- 2
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
7 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 3
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Proteon Therapeutics (8)
Studies
Open first, then newest update. How each study uses cholesterol-binding protein is read from its arms, and is right about nine times in ten.
Testing it · 8
- A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)CompletedPhase 3Proteon TherapeuticsNCT02414841Written as Vonapanitase
- A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)CompletedPhase 3Proteon TherapeuticsNCT02110901Written as PRT-201
- Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)CompletedPhase 1Proteon TherapeuticsNCT02956993Written as vonapanitase
- Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal ArteriesWithdrawnPhase 1Proteon TherapeuticsNCT02953496Written as vonapanitase
- Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)CompletedPhase 1Proteon TherapeuticsNCT01616290Written as PRT-201
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) PatientsCompletedPhase 1/2Proteon TherapeuticsNCT00679991Written as PRT-201
- A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney DiseaseCompletedPhase 2Proteon TherapeuticsNCT01305824Written as PRT-201
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney DiseaseCompletedPhase 1/2Proteon TherapeuticsNCT01001351Written as PRT-201